Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SULT2B1 |
| Upstream (Parents) |
|---|
| (<<) ADCY7 → SULT2B1 |
| (<<) ALOX15B → SULT2B1 |
| (<<) CLCF1 → SULT2B1 |
| (<<) CMTM7 → SULT2B1 |
| (<<) EPN3 → SULT2B1 |
| (<<) ERBB2 → SULT2B1 |
| (<<) FAM83A → SULT2B1 |
| (<<) FZD6 → SULT2B1 |
| (<<) GLS → SULT2B1 |
| (<<) GPR153 → SULT2B1 |
| (<<) GYS1 → SULT2B1 |
| (<<) HLA-DOA → SULT2B1 |
| (<<) HSPB1 → SULT2B1 |
| (<<) IL20 → SULT2B1 |
| (<<) ITGB8 → SULT2B1 |
| (<<) MRAS → SULT2B1 |
| (<<) N4BP3 → SULT2B1 |
| (<<) NEDD4 → SULT2B1 |
| (<<) PRSS22 → SULT2B1 |
| (<<) RDH16 → SULT2B1 |
| (<<) RHOD → SULT2B1 |
| (<<) RNASE7 → SULT2B1 |
| Downstream (Children) |
|---|
| SULT2B1 → CNFN (>>) |
| SULT2B1 → DISP2 (>>) |
| SULT2B1 → GPRIN1 (>>) |
| SULT2B1 → HSD17B2 (>>) |
| SULT2B1 → LRRC8C (>>) |
| SULT2B1 → MBOAT2 (>>) |
| SULT2B1 → PDRG1 (>>) |
| SULT2B1 → SMURF2 (>>) |
| SULT2B1 → SPRR1B (>>) |
| SULT2B1 → SUFU (>>) |
| SULT2B1 → WNT7B (>>) |
